Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 409

1.

The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance.

Silber BY, Croft RJ, Papafotiou K, Stough C.

Psychopharmacology (Berl). 2006 Aug;187(2):154-69. Epub 2006 Jun 8.

PMID:
16761129
2.

An evaluation of the sensitivity of the standardised field sobriety tests to detect the presence of amphetamine.

Silber BY, Papafotiou K, Croft RJ, Stough CK.

Psychopharmacology (Berl). 2005 Oct;182(1):153-9. Epub 2005 Sep 29.

PMID:
15986192
3.

Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition.

Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells LT, Wang Y.

Psychopharmacology (Berl). 2005 Mar;178(2-3):296-302. Epub 2004 Sep 25.

PMID:
15452681
4.

The effects of dexamphetamine on simulated driving performance.

Silber BY, Papafotiou K, Croft RJ, Ogden E, Swann P, Stough C.

Psychopharmacology (Berl). 2005 May;179(3):536-43. Epub 2004 Dec 22.

PMID:
15614573
6.

Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.

Makris AP, Rush CR, Frederich RC, Taylor AC, Kelly TH.

Exp Clin Psychopharmacol. 2007 Apr;15(2):123-33.

PMID:
17469936
7.

MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.

Kuypers KP, Samyn N, Ramaekers JG.

Psychopharmacology (Berl). 2006 Sep;187(4):467-75. Epub 2006 Jul 8.

PMID:
16830130
9.

[Driving under the influence of amphetamine and metamphetamine].

Lia K, Spigset O, Slørdal L.

Tidsskr Nor Laegeforen. 2009 Jan 15;129(2):105-8. doi: 10.4045/tidsskr.09.34091. Norwegian.

10.

Beyond drug effects and dependent variables: the use of the Poisson-Erlang model to assess the effects of D-amphetamine on information processing.

Halliday R, Gregory K, Naylor H, Callaway E, Yano L.

Acta Psychol (Amst). 1990 Feb;73(1):35-54.

PMID:
2180255
11.

The acute effects of d-amphetamine and d-methamphetamine on ERP components in humans.

Silber B, Croft R, Camfield DA, Downey LA, Papafotiou K, Stough C.

Eur Neuropsychopharmacol. 2012 Jul;22(7):492-500. doi: 10.1016/j.euroneuro.2011.11.009. Epub 2011 Dec 29.

PMID:
22209365
12.

The effect of d-methamphetamine on simulated driving performance.

Silber BY, Croft RJ, Downey LA, Papafotiou K, Camfield DA, Stough C.

Hum Psychopharmacol. 2012 Mar;27(2):139-44. doi: 10.1002/hup.1238.

PMID:
22389077
13.

Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.

Killgore WD, Rupp TL, Grugle NL, Reichardt RM, Lipizzi EL, Balkin TJ.

J Sleep Res. 2008 Sep;17(3):309-21. doi: 10.1111/j.1365-2869.2008.00654.x. Epub 2008 Jun 2.

14.

Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.

Lile JA, Stoops WW, Wagner FP, Glaser PE, Rush CR.

Pharmacol Biochem Behav. 2005 Oct;82(2):270-9. Epub 2005 Sep 22.

PMID:
16182353
15.

Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.

Leufkens TR, Vermeeren A, Smink BE, van Ruitenbeek P, Ramaekers JG.

Psychopharmacology (Berl). 2007 May;191(4):951-9. Epub 2007 Jan 12.

PMID:
17219217
16.

Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers.

Iwamoto K, Kawamura Y, Takahashi M, Uchiyama Y, Ebe K, Yoshida K, Iidaka T, Noda Y, Ozaki N.

Psychiatry Clin Neurosci. 2008 Oct;62(5):610-6. doi: 10.1111/j.1440-1819.2008.01838.x.

17.

The effect of d,l-methamphetamine on simulated driving performance.

Silber BY, Croft RJ, Downey LA, Camfield DA, Papafotiou K, Swann P, Stough C.

Psychopharmacology (Berl). 2012 Feb;219(4):1081-7. doi: 10.1007/s00213-011-2437-7. Epub 2011 Aug 13.

PMID:
21842157
18.

Effects of d-amphetamine on simulated driving performance before and after sleep deprivation.

Hjälmdahl M, Vadeby A, Forsman A, Fors C, Ceder G, Woxler P, Kronstrand R.

Psychopharmacology (Berl). 2012 Aug;222(3):401-11. doi: 10.1007/s00213-012-2744-7. Epub 2012 May 26.

PMID:
22638811
19.

Human pharmacology of the methamphetamine stereoisomers.

Mendelson J, Uemura N, Harris D, Nath RP, Fernandez E, Jacob P 3rd, Everhart ET, Jones RT.

Clin Pharmacol Ther. 2006 Oct;80(4):403-20.

PMID:
17015058
20.

Attentional control and brain metabolite levels in methamphetamine abusers.

Salo R, Nordahl TE, Natsuaki Y, Leamon MH, Galloway GP, Waters C, Moore CD, Buonocore MH.

Biol Psychiatry. 2007 Jun 1;61(11):1272-80. Epub 2006 Nov 9.

PMID:
17097074

Supplemental Content

Support Center